IQVIA艾昆纬：2026年弥合语言鸿沟-通过翻译加强临床试验白皮书（英文版）

Effective translation is essential to running faster, higher‑quality global clinical trials. Poorly executed language solutions can delay studies, increase costs, and introduce risk. But when built with the right clinical expertise and technology, translation becomes a strategic driver of patient engagement, regulatory readiness, and R&D acceleration.This IQVIA white paper, developed in conjunction with Fierce Pharma, highlights how sponsors can optimize study performance with specialized